These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7296816)

  • 1. Serum triglyceride levels in uremic patients receiving polyacrylonitrile dialysis.
    Severini G; Buongiorno A
    Clin Biochem; 1981 Apr; 14(2):72-3. PubMed ID: 7296816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biofiltration in uremic children.
    De Palo T; Sorino P; Bellantuono R; Colella V; Caringella DA
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():89-91. PubMed ID: 3557683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis].
    Peona C; Fortina A; Colombo P; Filiberti O; Cagna G; Costantini L; Porcu M
    Minerva Urol Nefrol; 1991; 43(3):175-9. PubMed ID: 1726274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of membrane characteristics on tumour necrosis factor kinetics during haemodialysis.
    Ghysen J; De Plaen JF; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1990; 5(4):270-4. PubMed ID: 2113223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of serum lipid abnormalities in chronic hemodialysis.
    Brunzell JD; Albers JJ; Haas LB; Goldberg AP; Agadoa L; Sherrard DJ
    Metabolism; 1977 Aug; 26(8):903-10. PubMed ID: 195181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of cytokines in hemodialysis.
    Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
    Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Miner Electrolyte Metab; 1999; 25(4-6):258-62. PubMed ID: 10681649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of 131I-beta2 microglobulin in hemodialysis patients: assessment using total body counting.
    Chanard J; Caudwell V; Valeire J; Vincent C; Randoux C; Wuillai A; Wynckel A
    Artif Organs; 1998 Jul; 22(7):574-80. PubMed ID: 9684694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood.
    Nguyen AT; Lethias C; Zingraff J; Herbelin A; Naret C; Descamps-Latscha B
    Kidney Int; 1985 Aug; 28(2):158-67. PubMed ID: 3834227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic neuropathy: clinical and neurophysiological investigation of dialysis patients using different chemical membranes.
    Violante F; Lorenzi S; Fusello M
    Eur Neurol; 1985; 24(6):398-404. PubMed ID: 4065159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical and clinical investigation of the RP6-rhodial 75 system. Evaluation of high and low middle molecular clearance dialysis.
    Jørstad S; Widerøe TE; Smedby L; Berg KJ; Wicks K
    Scand J Urol Nephrol; 1978; 12(2):167-74. PubMed ID: 694443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the AN69-S (Biospal) in conventional hemodialysis (HD) and in biofiltration (BF).
    Pisani E; Axia M; Morrone A; Carollo G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():75-7. PubMed ID: 3557679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.